ReviewDrug design, development and therapy2018

Inotuzumab ozogamicin: a CD22 mAb-drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Ilana R Yurkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.